As the view of psychiatric disorders becomes increasingly skewed toward biology at the exclusion of other factors, research like this should help to remind clinicians and researchers that there is more to treatment than simple pill dispensation.
Let me rephrase. It would help remind them if they were to actually notice studies such as this, but, unfortunately, this study will likely be read by few whereas poorly designed, tell us next to nothing clinical trials such as the recent Risperdal for depression study that I wrote much about (here, here, and here) will be read by thousands of docs. He who controls the distribution of information (via reprints, speakers, continuing medical education, etc.) controls clinical practice.